Incidence and Outcomes of Emergency Department Patients Requiring Emergency General Surgery

December 17, 2022 updated by: Christophe Fehlmann, University Hospital, Geneva
The objectives of this study were (1) to estimate the incidence of emergency general surgery in a Swiss University Hospital, (2) to describe the characteristics and outcomes of patients undergoing such interventions, and (3) to study the impact of age on the outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

310914

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients visiting the emergency department

Description

Inclusion Criteria:

- consecutive patients visiting the emergency department

Exclusion Criteria:

  • admitted primarily for a psychiatric reason
  • left without consultation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ED patients
Other: Age (young versus older)
Age

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of emergency general surgery
Time Frame: Day 3
Emergency general surgery following ED visit
Day 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Admission to intensive care unit rate
Time Frame: During index hospitalization
Admission to intensive care unit
During index hospitalization
ICU length of stay
Time Frame: During index hospitalization
Number of days spent in the ICU during hospital stay
During index hospitalization
30-day mortality rate
Time Frame: 30 days
30-day mortality
30 days
90-day mortality rate
Time Frame: 90 days
90-day mortality
90 days
One-year mortality rate
Time Frame: One year
One-year mortality
One year
Hospital length of stay
Time Frame: During index hospitalization
Hospital length of stay
During index hospitalization
Rate of patient dependent at discharge
Time Frame: Hospital discharge
Dependent at discharge
Hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Geneva

Investigators

  • Principal Investigator: Christophe A Fehlmann, MD, Genava University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

March 15, 2022

Study Completion (Actual)

March 15, 2022

Study Registration Dates

First Submitted

December 9, 2022

First Submitted That Met QC Criteria

December 17, 2022

First Posted (Estimate)

December 23, 2022

Study Record Updates

Last Update Posted (Estimate)

December 23, 2022

Last Update Submitted That Met QC Criteria

December 17, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EGS1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Sharing Time Frame

As soon as published

IPD Sharing Access Criteria

Without restriction

IPD Sharing Supporting Information Type

  • Analytic Code

Study Data/Documents

  1. Individual Participant Data Set

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergency General Surgery

Clinical Trials on Age (young versus older)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe